benzeneboronic acid has been researched along with arginyl-glycyl-aspartic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cui, W; Guo, B; He, F; Li, B; Ma, Y; Pan, G; Shea, KJ; Yang, H | 1 |
Ding, D; Hu, S; Liang, R; Shao, J; Wei, B; Wei, H; Zheng, X; Zhu, X | 1 |
Jia, R; Jia, Y; Liu, J; Taledaohan, A; Wang, X; Wang, Y | 1 |
3 other study(ies) available for benzeneboronic acid and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Dynamic introduction of cell adhesive factor via reversible multicovalent phenylboronic acid/cis-diol polymeric complexes.
Topics: Biocompatible Materials; Boronic Acids; Cell Adhesion; Cell Line; Fructose; Glucose; Humans; Oligopeptides; Polymers | 2014 |
A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer.
Topics: Animals; Boronic Acids; Cell Line, Tumor; Chitosan; Female; Humans; Indocyanine Green; Mice, Inbred BALB C; Multifunctional Nanoparticles; Oligopeptides; Phototherapy; Photothermal Therapy; Polymers; Reactive Oxygen Species; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis.
Topics: Animals; Chitosan; Lung Neoplasms; Mice; Nanomedicine; Neutrophils; Oligopeptides; Protein-Arginine Deiminase Type 4; Tumor Microenvironment | 2023 |